{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Viscum album", "antioxidant", "cancer", "flavonoids", "immunity", "inflammation", "lectins", "microProteins", "viscotoxins"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37050086", "DateRevised": {"Year": "2023", "Month": "09", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "27"}], "Language": ["eng"], "ELocationID": ["1460", "10.3390/plants12071460"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "12", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "27"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "The Anti-Inflammatory Activity of <i>Viscum album</i>.", "Abstract": {"AbstractText": ["The therapeutic story of European mistletoe (<i>Viscum album</i> L.) presents a seesawing profile. In ancient times, this hemiparasitic plant was considered a panacea and even to be endowed with exceptional beneficial properties. In more recent times, despite its multiple uses in traditional medicines, some parts of the plant, in particular the berries, were considered poisonous and dangerous, including concerns of cytotoxicity, which spread serious suspicion on its medicinal utility. However, since the last century, medical interest in mistletoe has come back in force due to its utilization in clinical cancer treatments, based on its selective action on tumor cells. In Central Europe, the hydro-alcoholic extracts of European mistletoe register a relevant and continuous utilization in anthroposophic medicine, which is a holistic system that includes the utilization of phytomedicinal substances. In Switzerland and Germany, most physicians and patients use these products as complementary therapy in oncological treatments. However, despite its increasing use in this field, the results of mistletoe's use are not always convincing, and other aspects have appeared. Nowadays, products that contain mistletoe are utilized in several fields, including diet, phytotherapy, veterinary medicine and homeopathy, but in particular in cancer therapies as coadjuvant factors, in consideration of several positive effects including effects in the improvement of quality-of-life conditions and reinforcement of the immune system. In this review, based on the understanding of the association between cancer and inflammation, we propose a relationship between these recent uses of mistletoe, based on its antioxidant properties, which are supported by phytochemical and pharmacological data. The unicity of mistletoe metabolism, which is a direct consequence of its hemiparasitism, is utilized as a key interpretation element to explain its biological properties and steer its consequent therapeutic uses."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Biology, Sapienza University of Rome, 00185 Rome, Italy."}], "LastName": "Nicoletti", "ForeName": "Marcello", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The author declares no personal circumstances that may be perceived as inappropriately influencing the representation or interpretation of the reported considerations."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bremer B., Bremer K., Chase M.W., Reveal J.L., Soltis D.E., Soltis P.S., Stevens P.F. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG II. Bot. J. Linn. Soc. 2003;141:399\u2013436."}, {"Citation": "Christenhusz M.J.M., Fay M.F., Chase M.W. Plants of the World. The University of Chicago Press; Chicago, IL, USA: 2017. pp. 426\u2013427. Kew Publishing Royal Botanical Kew."}, {"Citation": "B\u00fcssing A., editor. Mistletoe, The Genus Viscum (Medicinal and Aromatic Plants-Industrial Profiles) Harwood Academic Publishers, CRC; Amsterdam, The Netherlands: 2000."}, {"Citation": "Zube D. Biological flora of Central Europa: Viscum album L. Flora. 2004;199:181\u2013203. doi: 10.1078/0367-2530-00147.", "ArticleIdList": ["10.1078/0367-2530-00147"]}, {"Citation": "Oluwaseun A.A., Ganiu O. Antioxidant properties of methanolic extracts of mistletoe (Viscum album L.) from cocoa and cashew trees in Nigeria. Afr. J. Biotechnol. 2008;7:3138\u20133142."}, {"Citation": "Pfiz M., Kuppers M. Dense crowns of the hemiparasitic mistletoe Viscum album exhibit shrub-like growth and high dry matter turnover. Flora. 2010;205:787\u2013796. doi: 10.1016/j.flora.2010.04.016.", "ArticleIdList": ["10.1016/j.flora.2010.04.016"]}, {"Citation": "Thoday D. The austorial system of Viscum album. J. Exp. Bot. 1981;2:1\u201319. doi: 10.1093/jxb/2.1.1-a.", "ArticleIdList": ["10.1093/jxb/2.1.1-a"]}, {"Citation": "Chase M.W., Reveal J.L. A Phylogenetics classification of the land plants to accompany APG-III. Bot. J. Lin. Soc. Lond. 2009;161:122\u2013127. doi: 10.1111/j.1095-8339.2009.01002.x.", "ArticleIdList": ["10.1111/j.1095-8339.2009.01002.x"]}, {"Citation": "Fineren B.A. Root Parasitism in Santalaceae. Nature. 1963;197:65. doi: 10.1038/197095a0.", "ArticleIdList": ["10.1038/197095a0"]}, {"Citation": "Geils B.W., Hawksworth F.G. Mistletoes of North America Conifers. USDA; Washington, DC, USA: 2002. Damage, effect and importance of dwarf mistletoes; pp. 57\u201365."}, {"Citation": "Noetzli K.P., Sieber T.N. Impact of population dynamics of white mistletoe (Viscum album ssp. abietis) on European silver fir (Abies alba) Ann. For. Sci. 2003;60:773\u2013779. doi: 10.1051/forest:2003072.", "ArticleIdList": ["10.1051/forest:2003072"]}, {"Citation": "Briggs J. Mistletoe, Viscum album (Santalaceae), in Britain and Ireland; A discussion and review of current status and trends. Br. Ir. Bot. 2021;3:419\u2013454. doi: 10.33928/bib.2021.03.419.", "ArticleIdList": ["10.33928/bib.2021.03.419"]}, {"Citation": "Briggs J. Mistletoe-distribution, biology and the National Survey. Br. Wildl. 1999;7:75\u201382."}, {"Citation": "Novak P., Guignard M.S., Neumann L.J., Mlinares J., Koblizkav\u00e0 A., Dodsworth S., Kovaric A., Pellicer J., Wang W., Maca J. Repeat-sequence turnover shifts fundamentally in species with large genomes. Nat. Plants. 2020;6:1325\u20131329. doi: 10.1038/s41477-020-00785-x.", "ArticleIdList": ["10.1038/s41477-020-00785-x", "33077876"]}, {"Citation": "Hud\u00e1k J., Lux A. Chloroplast ultrastructure of semiparasitic Viscum album L. Photosynthetica. 1986;20:223\u2013224."}, {"Citation": "Senkler J., Rugen N., Eubel H., Hegermann J., Braun H.P. Absence of Complex I Implicates Rearrangement of the Respiratory Chain in European Mistletoe. Curr. Biol. 2018;28:1606\u20131613. doi: 10.1016/j.cub.2018.03.050.", "ArticleIdList": ["10.1016/j.cub.2018.03.050", "29731306"]}, {"Citation": "Maclean A.E., Hertle A.P., Ligas O., Bock R., Balk J., Meyer E.H. Absence of complex I is associated with diminished respiratory chain function in European mistletoe. Curr. Biol. 2018;28:1614\u20131619. doi: 10.1016/j.cub.2018.03.036.", "ArticleIdList": ["10.1016/j.cub.2018.03.036", "29731304"]}, {"Citation": "Schroder L., Hegermann J., Pille P. The Photosynthesis Apparatus of European mistletoe (Viscum album) Plant Physiol. 2022;190:1869\u20131914. doi: 10.1093/plphys/kiac377.", "ArticleIdList": ["10.1093/plphys/kiac377", "PMC9614478", "35976139"]}, {"Citation": "Petersen G., Cuenca Navarro A., Moller I.M., Moller I.M. Massive gene loss in mistletoe (Viscum, Viscaceae) mitocondria. Sci. Rep. 2015;5:17599. doi: 10.1038/srep17588.", "ArticleIdList": ["10.1038/srep17588", "PMC4667250", "26625950"]}, {"Citation": "Ahmed Z., Dutt H.C. Restriction of Viscum album to Few Phorophytes in a Habitat with Diverse Type of Three Species. Austin J. Plant Biol. 2015;1:1010."}, {"Citation": "Nicoletti M. Insect-Borne Diseases in the 21st Century. Academic Press; London, UK: 2020."}, {"Citation": "Barney C.W., Hansksworth F.G., Geils B.W. Hosts of Viscum album. Eur. J. For. Pathol. 1998;28:187\u2013208. doi: 10.1111/j.1439-0329.1998.tb01249.x.", "ArticleIdList": ["10.1111/j.1439-0329.1998.tb01249.x"]}, {"Citation": "Walas \u0141., K\u0119dziora W., Ksepko M., Rabska M., Tomaskewski D., Thomas P.A., W\u00f2jcik R., Iszkulo G. The future of Viscum album L. in Europe will be shaped by temperature and host availability. Sci. Rep. 2020;12:17072. doi: 10.1038/s41598-022-21532-6.", "ArticleIdList": ["10.1038/s41598-022-21532-6", "PMC9556578", "36224233"]}, {"Citation": "Piter\u00e0 F., Nicoletti M. Gemmotherapy, and the Scientific Foundations of a Modern Meristemotherapy. Cambridge Scholars Publishing; Newcastle upon Tyne, UK: 2020. pp. 402\u2013406."}, {"Citation": "Escher P., Eiblmeier M., Hetzger I., Rennenberg H. Seasonal and spatial variation of carbohydrates in mistletoes (Viscum album) and the xylem sap of its hosts (Populus \u00d7 euamericana and Abies alba) Physiol. Plant. 2004;120:212\u2013219. doi: 10.1111/j.0031-9317.2004.0230.x.", "ArticleIdList": ["10.1111/j.0031-9317.2004.0230.x", "15032855"]}, {"Citation": "Ture C., Bocuk H., Asan Z. Nutritional relationships between hemiparasitic mistletoe and some of its deciduous hots in different habitats. Biologia. 2010;65:859\u2013867. doi: 10.2478/s11756-010-0088-5.", "ArticleIdList": ["10.2478/s11756-010-0088-5"]}, {"Citation": "Escher P., Eibimeier M., Rememberg H. Differences in the influx of glutamine and nitrates into Viscum album from the xylem sap of its hosts. Plant Physiol. Biochem. 2004;42:739\u2013744. doi: 10.1016/j.plaphy.2004.07.009.", "ArticleIdList": ["10.1016/j.plaphy.2004.07.009", "15474380"]}, {"Citation": "Escher P., Rennenberg H. Influx of double labelled glutamine into mistletoe (Viscum album) from the xylem sap of its host (Abies alba) Plant Physiol. Biochem. 2008;44:890\u2013894.", "ArticleIdList": ["17095236"]}, {"Citation": "Okubamichael D., Griffiths M.E., Ward D. Host specificity, nutrient and water dynamics of the mistletoe Viscum rotundifolium and its potential host species in the Kalahari of South Africa. J. Arid Environ. 2011;75:898\u2013902. doi: 10.1016/j.jaridenv.2011.04.026.", "ArticleIdList": ["10.1016/j.jaridenv.2011.04.026"]}, {"Citation": "Escher P., Eibimeier M., Hetzer I., Rennemberg H. Seasonal and spatial variations of reduced sulphur compounds in mistletoe (Viscum album) and the xylem sap of its hosts (Populus euroamericana and Abies alba) Physiol. Plant. 2002;117:72\u201378. doi: 10.1034/j.1399-3054.2003.1170109.x.", "ArticleIdList": ["10.1034/j.1399-3054.2003.1170109.x"]}, {"Citation": "Skrypnik L., Maslennikov P., Feduraev P., Pungin A., Belov N. Changes in Antioxidative Compounds and Enzymes in Small-Leaved Linden (Tilia cordata Mill.) in Response to Mistletoe (Viscum album L.) Infestation. Plants. 2021;10:1871. doi: 10.3390/plants10091871.", "ArticleIdList": ["10.3390/plants10091871", "PMC8465490", "34579405"]}, {"Citation": "Nazaruk J., Orikowki P. Phytochemical profile and therapeutical potential of Viscum album L. Nat. Prod. Res. 2016;30:373\u2013395. doi: 10.1080/14786419.2015.1022776.", "ArticleIdList": ["10.1080/14786419.2015.1022776", "25813519"]}, {"Citation": "Amer B., Juvik O.J., Dupont F., Francis G.W., Fossen T. Novel aminoalkaloids from European mistletoe (Viscum album L.) Phytochem. Lett. 2012;5:677\u2013681. doi: 10.1016/j.phytol.2012.07.005.", "ArticleIdList": ["10.1016/j.phytol.2012.07.005"]}, {"Citation": "Pfuller U. Chemical constituents of European Mistletoe Viscum album L. In: Bussing A., editor. The Genus Viscum (Medicinal and Aromatic Plants-Industrial Profiles. Harwood Academic Publishers, CRC; Amsterdam, The Netherlands: 2000. pp. 101\u2013122."}, {"Citation": "Jager T., Holandino C., Rehman M.N., Condori Penazola E.M., Oliveira A.P., Garrett R., Glauser G., Grazi M., Ramm H., Urech K., et al. Metabolomic by UHPLC-Q-TOF reveals host tree-dependent phytochemical variation in Viscum album L. Plants. 2021;10:1726. doi: 10.3390/plants10081726.", "ArticleIdList": ["10.3390/plants10081726", "PMC8399568", "34451771"]}, {"Citation": "Urech K., Baumgartner S. Chemical constituents of Viscum album L.: Implications for the pharmaceutical preparation of mistletoe. Transl. Res. Biomed. 2015;4:23."}, {"Citation": "Segneanu A.-E., Marin C.N., Herea D.D., Stanusoiu J., Muntean C., Grozescu J. Romanian Viscum album, L.-Untargeted Low-Molecular Metabolomic Approach to Engineered Viscum-AuNPs Carrier Assembly. Plants. 2022;11:1820. doi: 10.3390/plants11141820.", "ArticleIdList": ["10.3390/plants11141820", "PMC9316836", "35890454"]}, {"Citation": "Song C., Wei X.-Y., Qiu Z.-D., Gong L., Chen Z.-Y., Ma Y., Shen Y., Zhao Y.-J., Wang W.-H., Lai C.-J.-S., et al. Exploring the resources of the genus Viscum for potential therapeutic applications. J. Ethnopharmacol. 2021;277:114233. doi: 10.1016/j.jep.2021.114233.", "ArticleIdList": ["10.1016/j.jep.2021.114233", "34044077"]}, {"Citation": "Becker H., Exner J. Comparative Studies of Flavonoids and Phenylcarboxylic Acids of Mistletoes from Different Host Trees. Z. Pflanzenphysiol. 1980;97:417\u2013428. doi: 10.1016/S0044-328X(80)80016-X.", "ArticleIdList": ["10.1016/S0044-328X(80)80016-X"]}, {"Citation": "Ochocka J.R., Piotrowski A. Biologically active compounds from European mistletoe (Viscum album L.) Can. J. Plant Pathol. 2002;24:21\u201328. doi: 10.1080/07060660109506966.", "ArticleIdList": ["10.1080/07060660109506966"]}, {"Citation": "W\u00f3jciak-Kosior M., Sowa I., Pucek K., Szymczak G., Kocjan R., Luchowsli P. Evaluation of seasonal changes of triterpenic acid contents in Viscum album from different host trees. Pharm. Biol. 2017;55:1\u20134. doi: 10.1080/13880209.2016.1225773.", "ArticleIdList": ["10.1080/13880209.2016.1225773", "PMC7011989", "27593449"]}, {"Citation": "Pietrzak W., Nowak R. Impact of Harvest Conditions and Host Tree Species on Chemical Composition and Antioxidant Activity of Extracts from Viscum album L. Molecules. 2021;26:3741. doi: 10.3390/molecules26123741.", "ArticleIdList": ["10.3390/molecules26123741", "PMC8233733", "34205329"]}, {"Citation": "Szurpnicka A., Zjawiony J.K., Szterk A. Therapeutic Potential of Mistletoe in CNS-Related Neurological Disorders and the Chemical Composition of Viscum Species. J. Ethnopharmacol. 2019;231:241\u2013252. doi: 10.1016/j.jep.2018.11.025.", "ArticleIdList": ["10.1016/j.jep.2018.11.025", "30458281"]}, {"Citation": "\u00d6nay-U\u00e7ar E., Karag\u00f6z A., Arda N. Antioxidant activity of Viscum album ssp. album. Fitoterapia. 2006;77:556\u2013560. doi: 10.1016/j.fitote.2006.08.001.", "ArticleIdList": ["10.1016/j.fitote.2006.08.001", "17056203"]}, {"Citation": "Simona V., Rugina D., Socaciu C. Antioxidant activities of Viscum album\u2019s leaves from various host trees. Bull. Univ. Agric. Sci. Vet. Med. Cluj Napoca Agric. 2008;65:327\u2013332."}, {"Citation": "Pal A., Debreczeni J.E., Sevvana M., Gruene T., Kahle B., Zeeck A., Sheldrick G.M. Structures of viscotoxins A1 and B from European mistletoe solved using native data alone. Acta Crystallogr. D Biol. Crystallogr. 2008;64:985\u2013992. doi: 10.1107/S0907444908022646.", "ArticleIdList": ["10.1107/S0907444908022646", "18703848"]}, {"Citation": "Schaller G., Urech K., Giannattasio M. Cytotoxicity of different viscotoxins and extracts from the European subspecies of Viscum album L. Phyther. Res. 1996;10:473\u2013477. doi: 10.1002/(SICI)1099-1573(199609)10:6<473::AID-PTR879>3.0.CO;2-Q.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199609)10:6<473::AID-PTR879>3.0.CO;2-Q"]}, {"Citation": "Jaggy C., Musielski H., Urech K., Schaller G. Quantitative determination of lectins in mistletoe preparations. Arzneim. Forsch./Drug Res. 1995;45:905\u2013909.", "ArticleIdList": ["7575759"]}, {"Citation": "Urech K., Schaller G., J\u00e4ggy C. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung. 2011;56:428\u2013434. doi: 10.1055/s-0031-1296808.", "ArticleIdList": ["10.1055/s-0031-1296808", "16927522"]}, {"Citation": "Majeed M., Rehman R.U. Phytochemistry, Pharmacology, and Toxicity of an Epiphytic Medicinal Shrub Viscum album L. (White Berry Mistletoe) In: Aftab T., Hakeem K.R., editors. Medicinal and Aromatic Plants. Springer; Cham, Switzerland: 2021. pp. 287\u2013301."}, {"Citation": "Zhang R.-Z., Zhao J.-T., Wang W.-Q., Fan R.-H., Rong R., Yu Z.-G., Zhang Y.-L. Metabolomics-based comparative analysis of the effects of host and environment on Viscum coloratum metabolites and antioxidative activities. J. Pharm. Anal. 2022;12:243\u2013252. doi: 10.1016/j.jpha.2021.04.003.", "ArticleIdList": ["10.1016/j.jpha.2021.04.003", "PMC9091737", "35582400"]}, {"Citation": "Schaller G., Urech K., Grazi G., Giannattasio M. Viscotoxin composition of the three European subspecies of Viscum album. Planta Med. 1998;64:677\u2013678. doi: 10.1055/s-2006-957553.", "ArticleIdList": ["10.1055/s-2006-957553", "17253311"]}, {"Citation": "Beuth J., Stoffel B., Ko H.L., Jeljaszewiz J., Pulverer G. Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract. Arzneimittelforshung. 1995;45:1240\u20131242.", "ArticleIdList": ["8929248"]}, {"Citation": "Segneanu A., Velciov S.M., Olariu S., Cziple F., Damian D., Grozescu I. Bioactive molecules profile from natural compounds. In: Asao T., Asaduzzaman M., editors. Amino Acid-New Insights and Roles in Plant and Animal. IntechOpen; Rijeka, Croatia: 2017."}, {"Citation": "Wilson H.A., Huang W., Waldrip J.B., Judd A.M., Vernon L.P., Bell J.D. Mechanisms by which thionin induces susceptibility of S49 cell membranes to extracellular phospholipase A2. Biochim Biophys Acta. 1997;1349:142\u2013156. doi: 10.1016/S0005-2760(97)00089-1.", "ArticleIdList": ["10.1016/S0005-2760(97)00089-1", "9421187"]}, {"Citation": "Olnes S., Stirpe F., Sandvig K., Phil A. Isolation and Characterization of Viscumin, a toxic lectin from Viscum album L. (mistletoe) J. Biol. Chem. 1982;257:13263\u201313270. doi: 10.1016/S0021-9258(18)33440-9.", "ArticleIdList": ["10.1016/S0021-9258(18)33440-9", "7142144"]}, {"Citation": "Bergmann L., Aamdal S., Marreaud S., Lacombe D., Herold M., Yamagichi T., Wilhelm-Ogunbiyi K., Lentzen H., Zwirzina H. European Organisation for Research and Treatment of Cancer: Phase I trial of r viscumin (INN: Aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001) Eur. J. Cancer. 2008;44:1657\u20131662.", "ArticleIdList": ["18602257"]}, {"Citation": "Adler M., Langer M., Witthohn K., Eck J., Blohm D., Niemeyer C.M. Detection of rViscumin in plasma samples by immunoPCR. Biochem. Biophys. Res. Commun. 2003;300:757\u2013763. doi: 10.1016/S0006-291X(02)02912-1.", "ArticleIdList": ["10.1016/S0006-291X(02)02912-1", "12507515"]}, {"Citation": "Zwierzina H., Bergmann L., Fiebig H., Aamdal S., Schoffski P., Wittholm K., Lentzen H. The preclinical and clinical activity of aviscumine: A potential anticancer drug. Eur. J. Cancer. 2011;47:1450\u20131457. doi: 10.1016/j.ejca.2011.02.022.", "ArticleIdList": ["10.1016/j.ejca.2011.02.022", "21482461"]}, {"Citation": "Abuharbeid S., Apel J., Sander M., Fiedeler B., Langer M., Zuzarte M. Cytotoxicity of the novel anti-cancer drug Viscumin depends on HER-2 levels in SKOV-3 cells. Biochem. Biophys. Res. Commun. 2004;321:403\u2013412. doi: 10.1016/j.bbrc.2004.06.160.", "ArticleIdList": ["10.1016/j.bbrc.2004.06.160", "15358191"]}, {"Citation": "Niwa H., Tonevitsky A.G., Agapov S.S., Saward S., Pfuller U., Palmer R.A. Crystal structure at 3 A of mistletoe lectin I, a dimeric type-II ribosome-inactivating protein, complexed with galactose. Eur. J. Biochem. 2003;270:2739\u20132749. doi: 10.1046/j.1432-1033.2003.03646.x.", "ArticleIdList": ["10.1046/j.1432-1033.2003.03646.x", "12823544"]}, {"Citation": "Ahmad M.S., Rasheed S., Felke S., Khaliq B., Perbandt M., Choudhary M.I., Markiewick W.T., Barciszewski J., Betzel C. Crystal Structure of Mistletoe Lectin I (ML-I) from Viscum album in Complex with 4-N-Furfurylcytosine at 2.85 \u00c5 Resolution. Med. Chem. 2018;14:754\u2013763. doi: 10.2174/1573406414666180524095946.", "ArticleIdList": ["10.2174/1573406414666180524095946", "29792147"]}, {"Citation": "Krauspenhaar R., Eschenburg S., Perbandt M., Kaur P., Yadav S., Krauspenhaaar R., Beltzel C., Voelter W., Babu C.R., Singh T.P. Crystal structure of mistletoe lectin I from Viscum album. Biochem. Biophys. Res. Commun. 1999;257:418\u2013424. doi: 10.1006/bbrc.1999.0470.", "ArticleIdList": ["10.1006/bbrc.1999.0470", "10198229"]}, {"Citation": "B\u00fcssing A., Suzart K., Schweizer K. Differences in the apoptosis-inducing properties of Viscum album L. extracts. Anti-Cancer Drugs. 1997;8((Suppl. S1)):S9\u2013S14. doi: 10.1097/00001813-199704001-00003.", "ArticleIdList": ["10.1097/00001813-199704001-00003", "9179360"]}, {"Citation": "Vervecken W., Kleff S., Pf\u00fcller U., B\u00fcssing A. Induction of apoptosis by mistletoe lectin I and its subunits. No evidence for cytotoxic effects caused by isolated A- and B-chains. Int. J. Biochem. Cell Biol. 2000;32:317\u2013326. doi: 10.1016/S1357-2725(99)00135-1.", "ArticleIdList": ["10.1016/S1357-2725(99)00135-1", "10716629"]}, {"Citation": "Franz H. Mistletoe lectins and their A and B chains. Oncology. 1986;43((Suppl. S1)):23\u201334. doi: 10.1159/000226417.", "ArticleIdList": ["10.1159/000226417", "3543782"]}, {"Citation": "Franz H. Mistletoe Lectins. In: Franz H., editor. Advances in Lectin Research. Springer; Berlin/Heidelberg, Germany: 1991. pp. 33\u201350. Chapter 2."}, {"Citation": "Eugen T., Staub D., Graaff M., Wenlel S. MicroProteins: Small size-big impact. Trends Plant Sci. 2015;20:477\u2013482. doi: 10.1016/j.tplants.2015.05.011.", "ArticleIdList": ["10.1016/j.tplants.2015.05.011", "26115780"]}, {"Citation": "Bhate K.K., Dolde V., Wenkel S. MicroProteins: Expanding functions and novel modes of regulation. Mol. Plant. 2021;14:705\u2013707. doi: 10.1016/j.molp.2021.01.006.", "ArticleIdList": ["10.1016/j.molp.2021.01.006", "33450370"]}, {"Citation": "Kushwaha A.K., Dwivedi S., Mukherejee A., Lingwan M., Dar M.A., Bhagavatula L., Datta S. Plant microProteins. Small but powerful modulators of plant development. Science. 2022;25:105400. doi: 10.1016/j.isci.2022.105400.", "ArticleIdList": ["10.1016/j.isci.2022.105400", "PMC9638782", "36353725"]}, {"Citation": "Zuber D., Widmer A. Phylogeography and host race differentiation in the European mistletoe (Viscum album L.) Mol. Ecol. 2009;18:1946\u20131962. doi: 10.1111/j.1365-294X.2009.04168.x.", "ArticleIdList": ["10.1111/j.1365-294X.2009.04168.x", "19434811"]}, {"Citation": "Schrader-Fischer G., Apel K. The Anticyclic Timing of Leaf Senescence in the Parasitic Plant Viscum album is Closely Correlated with the Selective Degradation of Sulfur-Rich Viscotoxins. Plant Physiol. 1993;101:745\u2013749. doi: 10.1104/pp.101.3.745.", "ArticleIdList": ["10.1104/pp.101.3.745", "PMC158686", "12231725"]}, {"Citation": "Schroder L., Honyec N., Senkler M., Senkler M., Senkler J., Kuster H., Braun H.-P. The gene space of European Mistetoe (Viscum album) Plant J. 2022;109:278\u2013294. doi: 10.1111/tpj.15558.", "ArticleIdList": ["10.1111/tpj.15558", "34713513"]}, {"Citation": "Pe\u00f1aloza E., Holandino C., Scherr C., de Araujo P.I.P., Borges R.M., Urech K., Baumgartner S., Garrett R. Comprehensive metabolome analysis of fermented aqueous extracts of Viscum album L. by liquid chromatography\u2212high resolution tandem mass spectrometry. Molecules. 2020;25:4006. doi: 10.3390/molecules25174006.", "ArticleIdList": ["10.3390/molecules25174006", "PMC7504787", "32887375"]}, {"Citation": "Pietrzak W., Nowak R., Gawlik-Dziki U., Lemieszek M.K., Rzenski W. LC-ESI-MS/MS identification of biologically active phenolic compounds in mistletoe berry extracts from different host trees. Molecules. 2017;22:624. doi: 10.3390/molecules22040624.", "ArticleIdList": ["10.3390/molecules22040624", "PMC6154606", "28417943"]}, {"Citation": "Vanhaverbeke C., Jouboul D., Elie N., Pr\u00e9vost M., Meunier C., Michelland S., Cumin V., Ma L., Vermijlen D., Delporte C., et al. Untarget metabolomics approach to discriminate mistletoe commercial products. Sci. Rep. 2021;111:14205. doi: 10.1038/s41598-021-93255-z.", "ArticleIdList": ["10.1038/s41598-021-93255-z", "PMC8270909", "34244531"]}, {"Citation": "Zhang R.-Z., Zhao J.-T., Wang W.-Q. Phenolic compounds in chilean mistletoe (quintral, Tristerix tetrandus) analyzed by UHPLC-Q/Orbitrap/MS/MS and its antioxidant properties. Molecules. 2016;21:245.", "ArticleIdList": ["PMC6274319", "26907248"]}, {"Citation": "Luther P., Becker H. Die Mistel. Botanik, Lektine, Medizinische Anwendung. Springer; Berlin/Heidelberg, Germany: 1987."}, {"Citation": "B\u00fcssing A. History of mistletoe uses. In: B\u00fcssing A., editor. Mistletoe. The Genus Viscum. Harwood Academic Publishers; Amsterdam, The Netherlands: 2000. pp. 1\u20136."}, {"Citation": "Szurpnicka A., Kowalczuk A., Szterk A. Biological activity of mistletoe: In vitro and in vivo studies and mechanisms of action. Arch. Pharm. Res. 2020;43:593\u2013629. doi: 10.1007/s12272-020-01247-w.", "ArticleIdList": ["10.1007/s12272-020-01247-w", "PMC7340679", "32621089"]}, {"Citation": "Kleszken E., Timar A.V., Memete A.R., Miere F., Vicas S.I. On overview of bioactive compounds, biological and pharmacological effects of mistletoe (Viscum album L.) Pharmacophore. 2022;13:10\u201326. doi: 10.51847/Tmo2sXGQRs.", "ArticleIdList": ["10.51847/Tmo2sXGQRs"]}, {"Citation": "Ahmed S., Mir N.H., Sultan S.M. White berry mistletoe (Viscum album L.): A hemiparasitic plant: Occurrence and ethnobotanical use in Kashmir. J. Pharmacol. Phytochem. 2011;7:1831\u20131833."}, {"Citation": "Bulut G., Haznederoglu H.Z., Dogan A. An ethnobotanical study of medicinal plants in Acyoayam (Denizli-Turkey) J. Herb. Med. 2017;10:64\u201381. doi: 10.1016/j.hermed.2017.08.001.", "ArticleIdList": ["10.1016/j.hermed.2017.08.001"]}, {"Citation": "Maruca G., Spampinato G., Turiano D., Laghetti C., Musarella C.M. Ethnobotanical notes about medicinal and useful plants of the Reventino Massif tradition (Calabria region, Southern Italy) Genet. Resour. Crop Evol. 2019;66:1027\u20131040. doi: 10.1007/s10722-019-00768-8.", "ArticleIdList": ["10.1007/s10722-019-00768-8"]}, {"Citation": "Senkardes I., Dogan A., Emre G. An Ethnobotanical study of medicinal plants in Ta\u015fk\u00f6pr\u00fc (Kastamonu\u2013Turkey) Front. Pharmacol. 2022;13:984065. doi: 10.3389/fphar.2022.984065.", "ArticleIdList": ["10.3389/fphar.2022.984065", "PMC9630845", "36339567"]}, {"Citation": "Z\u00e4nker K.S., Kaveri S.V., editors. Mistletoe: From Mythology to Evidence-Based Medicine. Volume 4. Karger; Basel, Switzerland: 2015. pp. 1\u201310. Translational Research in Biomedicine."}, {"Citation": "Aldhouse-Green M. Caesar\u2019s Druids. Yale University Press; New Haven, CT, USA: 2010. The moon and the mistletoe in search of ancient druids: Story of an ancient priest-hood; p. 19. Chapter 1."}, {"Citation": "Secondum G.P. Naturalis Hystoria. Sillabe; Livorno, Italy: 2014. 16.248.1."}, {"Citation": "Lindow J. The tears of the Gods. A note on the death of Baidr in Scandinavian mythology. J. Engl. Ger. Philol. 2002;101:155\u2013169."}, {"Citation": "Azuma J., Kim N.H., Heux L., Vuong R., Chanzy H. The cellulose system in viscin from mistletoe berries. Cellulose. 2000;7:3\u201319. doi: 10.1023/A:1009223730317.", "ArticleIdList": ["10.1023/A:1009223730317"]}, {"Citation": "Holbelt H., Fratzel P., Harrison H.J. Mistletoe viscin: A hygro- and mechano-responsive cellulose-based adhesive for diverse material applications. PNAS Nexus. 2022;1:1\u201311.", "ArticleIdList": ["PMC9802232", "36712808"]}, {"Citation": "Singh B.N., Saha C., Galun D., Upreti D.K., Bayry J., Kaveri S.V. European Viscum album: A potent phytotherapeutic agent with multifarious phytochemicals, pharmacological properties and clinical evidence. RSC Adv. 2016;6:23837\u201323857. doi: 10.1039/C5RA27381A.", "ArticleIdList": ["10.1039/C5RA27381A"]}, {"Citation": "Lev E., Ephraim M., Ben-Arye E. European and Oriental mistletoe: From mythology to contemporary integrative cancer care. Eur. J. Integr. Med. 2011;3:e133\u2013e137. doi: 10.1016/j.eujim.2011.05.052.", "ArticleIdList": ["10.1016/j.eujim.2011.05.052"]}, {"Citation": "Cicchetti J.T. Viscum album\u2014Magical Plant of Complexity and Paradox. Homoepatic Links. 2005;28:118\u2013122."}, {"Citation": "Committee on Herbal Medicinal Products . Assessment Report on Viscum album L., Herba. Committee on Herbal Medicinal Product; London, UK: 2012."}, {"Citation": "Kiele G., Albonico H.-L., Baars E., Hamre H.J., Zimmermann P., Kiene H. Anthroposophic Medicine: An Integrative Medical System Originating in Europe. Glob. Adv. Health Med. 2013;2:20\u201331.", "ArticleIdList": ["PMC3865373", "24416705"]}, {"Citation": "Steiner R., Wegman I. Grundlegendes f\u00fcr eine Erweiterung der Heilkunst nach Geisteswissenschaftlichen Erkenntnissen. Schattauer Verlag; Stuttgart, Germany: New York, NY, USA: 1991."}, {"Citation": "Kienle G.S., Kiene H., Albonico H.U. Anthroposophic Medicine: Effectiveness, Utility, Costs, Safety. Schattauer Verlag; Stuttgart, Germany: New York, NY, USA: 2006."}, {"Citation": "Mengs H., Wittohn K., Scharzt T. Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties. Wien Med. Wochenschr. 1999;149:262\u2013264.", "ArticleIdList": ["10483695"]}, {"Citation": "Scott J.A., Kearney N., Hummerston S., Molassiotis A. Use of complementary and alternative medicine in patients with cancer: A UK survey. Eur. J. Oncol. Nurs. 2005;9:131\u2013137. doi: 10.1016/j.ejon.2005.03.012.", "ArticleIdList": ["10.1016/j.ejon.2005.03.012", "15944106"]}, {"Citation": "Kienle G.S., Glockmann A., Schink M., Kiene H. Viscum album L. extracts in breast and gynecological cancers: A systematic review of clinical and preclinical research. J. Exp. Clin. Cancer Res. 2009;28:79\u201385. doi: 10.1186/1756-9966-28-79.", "ArticleIdList": ["10.1186/1756-9966-28-79", "PMC2711058", "19519890"]}, {"Citation": "Horneber M.A., Bueschel G., Huber R., Linde K., Rostok M. Mistletoe therapy in oncology. Cochrane Database Syst. Rev. 2008;2:CD003297.", "ArticleIdList": ["PMC7144832", "18425885"]}, {"Citation": "Thronicke A., Steele M.L., Grah C., Hamre H.J., Zimmermann P., Kiene H. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. BMC Complement. Altern. Med. 2017;17:534. doi: 10.1186/s12906-017-2045-0.", "ArticleIdList": ["10.1186/s12906-017-2045-0", "PMC5729272", "29237435"]}, {"Citation": "Schaefermeyer G., Schaefermeyer H. Treatment of pancreatic cancer with Viscum album (Iscador): A retrospective study of 292 patients 1986\u20131996. Complement. Ther. Med. 1998;6:172\u2013177. doi: 10.1016/S0965-2299(98)80024-1.", "ArticleIdList": ["10.1016/S0965-2299(98)80024-1"]}, {"Citation": "Schnell-Inderst P., Steigenberger C., Mertz M., Otto I., Flatscher-Th\u00f6ni M., Siebert U. Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment. Ger. Med. Sci. 2022;20:10.", "ArticleIdList": ["PMC9487779", "36160875"]}, {"Citation": "Sch\u00f6tterl S., Miemietz J.T., Ilina E.I., Veninga V., Wirsik N.-M., Bernatz S., Lentzen H., Mittelbronn M., Naumann U. Mistletoe-based drugs work in synergy with radio-chemotherapy in the treatment of glioma in vitro and in vivo in glioblastoma bearing mice. Evid. Based Complement. Altern. Med. 2019;2019:1376140. doi: 10.1155/2019/1376140.", "ArticleIdList": ["10.1155/2019/1376140", "PMC6636536", "31354846"]}, {"Citation": "Kienle G., Berrino F., Bussing A., Portalupi E., Rosenzweig S., Kiene H. Mistletoe in cancer: A systematic review on controlled clinical trials. Eur. J. Med. Res. 2003;8:109\u2013119.", "ArticleIdList": ["12730032"]}, {"Citation": "Reynel M., Villegas Y., Kiene H. Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report. Medicine. 2018;97:e13420. doi: 10.1097/MD.0000000000013420.", "ArticleIdList": ["10.1097/MD.0000000000013420", "PMC6283068", "30508950"]}, {"Citation": "Oei S.L., Thronicke A., Kr\u00f6z M., von Trott P., Shad F., Mathes H. Impact of Oncological Therapy and Viscum album L. Treatment on Cancer-Related Fatigue and Internal Coherence in Nonmetastasized Breast Cancer Patients. Integr. Cancer Ther. 2020;19:1534735420917211. doi: 10.1177/1534735420917211.", "ArticleIdList": ["10.1177/1534735420917211", "PMC7273755", "32478590"]}, {"Citation": "Kienle G.S., Kiene H. Complementary cancer therapy: A systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur. J. Med. Res. 2007;12:103\u2013119.", "ArticleIdList": ["17507307"]}, {"Citation": "Valle A.C.V., Carvalho A.C. Viscum album in Medicine Article Review. Int. J. Sci. Res. (IJSR) 2021;10:42\u201348."}, {"Citation": "Freuding M., Keinki C., Kutschan S., Buentzel J., Huebner J. Mistletoe in oncological treatment: A systematic review: Part 1 survival and safety and Part 2: Quality of life and toxicity of cancer treatment. J. Cancer Res. Clin. Oncol. 2019;145:695\u2013707. doi: 10.1007/s00432-018-02838-3.", "ArticleIdList": ["10.1007/s00432-018-02838-3", "30673873"]}, {"Citation": "Ostermann T., Raak C., B\u00fcssing A. Survival of cancer patients treated with mistletoe extract (Iscador): A systematic literature review. BMC Cancer. 2009;9:451. doi: 10.1186/1471-2407-9-451.", "ArticleIdList": ["10.1186/1471-2407-9-451", "PMC2804713", "20021637"]}, {"Citation": "Goebell P.J., Otto T., Suhr J., Rubben H. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: A randomized phase II trial. J. Urol. 2002;168:72\u201375. doi: 10.1016/S0022-5347(05)64834-3.", "ArticleIdList": ["10.1016/S0022-5347(05)64834-3", "12050495"]}, {"Citation": "Cazacu M., Oniu T., Lungoci C., Mihailov A., Cipak A., Klinger R., Weiss T., Zarkovic N. The influence of isorel on the advanced colorectal cancer. Cancer Biother. Radiopharm. 2003;18:27\u201334. doi: 10.1089/108497803321269304.", "ArticleIdList": ["10.1089/108497803321269304", "12667306"]}, {"Citation": "Piao B.K., Wang Y.X., Xie G.R., Mansmann U., Matthes H., Benth J., Lin H.S. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res. 2004;24:303\u2013309.", "ArticleIdList": ["15015612"]}, {"Citation": "Semiglazov V.F., Stepula V.V., Dudov A., Dudov A., Schnitker J., Mengs U. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: A randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res. 2006;26:1519\u20131529.", "ArticleIdList": ["16619567"]}, {"Citation": "Kim S., Kim K.C., Lee C. Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells. Phytomedicine. 2017;36:183\u2013193. doi: 10.1016/j.phymed.2017.09.017.", "ArticleIdList": ["10.1016/j.phymed.2017.09.017", "29157814"]}, {"Citation": "Kim Y., Kim I., Park C.H., Kim J.B. Korean mistletoe lectin enhances natural killer cell cytotoxicity via upregulation of perforin expression. Asian Pac. J. Allergy Immunol. 2018;36:175\u2013183. doi: 10.1016/j.jaci.2017.12.556.", "ArticleIdList": ["10.1016/j.jaci.2017.12.556", "29602283"]}, {"Citation": "Kleeberg U.R., Suciu S., Brocker E.B., Ruiter D.J., Chartier C., Lienard D. Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness > 3 mm) or regional lymph node metastasis. Eur. J. Cancer. 2004;40:390\u2013402. doi: 10.1016/j.ejca.2003.07.004.", "ArticleIdList": ["10.1016/j.ejca.2003.07.004", "14746858"]}, {"Citation": "Klingbeil M.G., Xavier F.C.A., Sardinha L.R., Severino P., Mathor M., Rodriguez R.V. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines. Oncol. Rep. 2013;30:2316\u20132322. doi: 10.3892/or.2013.2732.", "ArticleIdList": ["10.3892/or.2013.2732", "24026291"]}, {"Citation": "Mazalovska M., Calvin Kouokam J. Plant-derived lectins as potential cancer therapeutics and diagnostic tools. BioMed Res. Int. 2020;2020:1631394. doi: 10.1155/2020/1631394.", "ArticleIdList": ["10.1155/2020/1631394", "PMC7245692", "32509848"]}, {"Citation": "Park R., Kim M.S., So H.S., Meyer C.F., Keesler G., Zukowsky M., Tan T.H., Zao Z. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells. Biochem. Pharm. 2000;60:1685\u20131691. doi: 10.1016/S0006-2952(00)00482-2.", "ArticleIdList": ["10.1016/S0006-2952(00)00482-2", "11077051"]}, {"Citation": "Park W.B., Lyu S.Y., Kim J.H., Chung H.K., Ahn S.H., Hong S.Y., Yoon T.J., Choi M.J. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biother. Radiopharm. 2001;16:439\u2013447. doi: 10.1089/108497801753354348.", "ArticleIdList": ["10.1089/108497801753354348", "11776761"]}, {"Citation": "Ernst E., Schmidt K., Steuer-Vogt M.K. Mistletoe for cancer? A systematic review of randomised clinical trials. Int. J. Cancer. 2003;107:262\u2013267. doi: 10.1002/ijc.11386.", "ArticleIdList": ["10.1002/ijc.11386", "12949804"]}, {"Citation": "Evans M., Bryant S., Huntley A.L., Feder G. Cancer patients\u2019 experiences of using mistletoe (Viscum album): A qualitative systematic review and synthesis. Altern. Complement. Med. 2016;22:134\u2013144. doi: 10.1089/acm.2015.0194.", "ArticleIdList": ["10.1089/acm.2015.0194", "26684278"]}, {"Citation": "Bar-Sela G. White-Berry Mistletoe (Viscum album L.) as complementary treatment in cancer: Does it help? Eur. J. Integr. Med. 2011;3:e55\u2013e62. doi: 10.1016/j.eujim.2011.03.002.", "ArticleIdList": ["10.1016/j.eujim.2011.03.002"]}, {"Citation": "Samtleben R., Hajto T., Hostanska K., Wagner H. Mistletoe lectins as immunostimulants (chemistry, pharmacology and clinic) In: Wagner H., editor. Immunomodulatory Agents from Plants. Birkhauser Verlag; Basel, Switzerland: 1999. pp. 223\u2013241."}, {"Citation": "Jurin M., Zarkovi\u0107 N., Hrzenjak M., Ilic Z. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel. Oncology. 1993;50:393\u2013398. doi: 10.1159/000227217.", "ArticleIdList": ["10.1159/000227217", "8233280"]}, {"Citation": "Jurin M., Zarkovic N., Borovic N., Kissel D. Viscum album L. preparation Isorel modifies the immune response in normal and cancer-bearing mice. Anticancer Drugs. 1997;8((Suppl. S1)):S27\u2013S31. doi: 10.1097/00001813-199704001-00007.", "ArticleIdList": ["10.1097/00001813-199704001-00007", "9179364"]}, {"Citation": "Wrotek S., Skawi\u0144ski R., Kozak W. Postepy. Immunostimulatory properties of mistletoe extracts and their application in oncology. Postpy Hig. Med. Dosw. 2014;68:1216\u20131224. doi: 10.5604/17322693.1126850.", "ArticleIdList": ["10.5604/17322693.1126850", "25380204"]}, {"Citation": "Van Wely M., Stoss M., Gorter R.W. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals. Am. J. Ther. 1999;6:37\u201343. doi: 10.1097/00045391-199901000-00006.", "ArticleIdList": ["10.1097/00045391-199901000-00006", "10423645"]}, {"Citation": "Gardin N.E. Immunological response to mistletoe (Viscum album L.) in cancer patients: A four-case series. Phytother. Res. 2009;23:407\u2013411. doi: 10.1002/ptr.2643.", "ArticleIdList": ["10.1002/ptr.2643", "19003944"]}, {"Citation": "Elluru S.R., van Huyen J.P.D., Delignat S., Kazatchkine M.D., Friboulet A., Kaveri S.V., Bayri J. Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer. 2008;8:161. doi: 10.1186/1471-2407-8-161.", "ArticleIdList": ["10.1186/1471-2407-8-161", "PMC2442603", "18533025"]}, {"Citation": "Hedge P., Maddur M.S., Friboulet A., Bayry J., Kaveri S.V. Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2. PLoS ONE. 2011;6:e26312.", "ArticleIdList": ["PMC3196571", "22028854"]}, {"Citation": "Elleru S.R., Maddur M.S., Friboulet A., Bayry J., Kaveri S.V. Dissecting the Anti-Inflammatory Effects of Viscum album: Inhibition of Cytokine-Induced Expression of Cyclo-Oxygenase-2 and Secretion of Prostaglandin E2. In: Z\u00e4nker K.S., Kaveri S.V., editors. Mistletoe: From Mythology to Evidence-Based Medicine. Volume 4. Karger; Basel, Switzerland: 2015. pp. 67\u201373. Translational Research in Biomedicine."}, {"Citation": "Duong Van Huyen J.P., Delignat D., Bayry J., Kazatchkine M.D., Bruneval P., Nicoletti A., Kaveri S.V. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. Cancer Lett. 2006;243:32\u201337. doi: 10.1016/j.canlet.2005.11.016.", "ArticleIdList": ["10.1016/j.canlet.2005.11.016", "16412563"]}, {"Citation": "Saha C., Hegde P., Friboulet A., Bayry J., Kaveri S.V. Viscum album-mediated COX-2 inhibition implicates destabilization of COX-2 mRNA. PLoS ONE. 2015;10:e0114965. doi: 10.1371/journal.pone.0114965.", "ArticleIdList": ["10.1371/journal.pone.0114965", "PMC4321838", "25664986"]}, {"Citation": "Ha S.-M., Kim J.-M., Kim J.-W. The potential Role of Korean Mistletoe as an Anti-inflammatory Suppletation. J. Immunol. Res. 2021;2021:2183427. doi: 10.1155/2021/2183427.", "ArticleIdList": ["10.1155/2021/2183427", "PMC8263236", "34307692"]}, {"Citation": "Bauer R., Becker H., Fintelmann V., Kemper F.H., Schilcher H., editors. Fortschritte in der Misteltherapie Aktueller Stand der Forschung und Klinischen Anwendung. KVC Verlag; Essen, Germany: 2005. pp. 543\u2013554."}, {"Citation": "Kim B.K., Choi M.J., Park K.Y., Cho E.J. Protective effects of Korean mistletoe lectin on radical-induced oxidative stress. Biol. Pharm. Bull. 2010;33:1152\u20131158. doi: 10.1248/bpb.33.1152.", "ArticleIdList": ["10.1248/bpb.33.1152", "20606306"]}, {"Citation": "Lavastre V., Cavelli H., Rathe C., Girard D. Anti-inflammatory effect of Viscum album agglutinin-I (VAA-I): Induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophilic inflammation in vivo. Clin. Exp. Immunol. 2004;137:272\u2013278. doi: 10.1111/j.1365-2249.2004.02545.x.", "ArticleIdList": ["10.1111/j.1365-2249.2004.02545.x", "PMC1809108", "15270843"]}, {"Citation": "Vica\u015f S.I., Rugin\u01ce D., Socaciu C. Comparative study about antioxidant activities of Viscum album from different host trees, harvested in different seasons. J. Med. Plants Res. 2011;5:2237\u20132244."}, {"Citation": "Yesilada E., Deliorman D., Ergun F., Takaishi Y., Ono Y. Effect of the Turkish subspecies of Viscum album on macrophage-derived cytokines. J. Ethnopharmacol. 1998;61:195\u2013200. doi: 10.1016/S0378-8741(98)00038-5.", "ArticleIdList": ["10.1016/S0378-8741(98)00038-5", "9705010"]}, {"Citation": "Pieme C.A., Ngogang J., Costache M. In vitro antiproliferative and anti-oxidant activities of methanol extracts of Urena lobata and Viscum album against breast cancer cell lines. Toxicol. Environ. Chem. 2012;94:987\u2013999. doi: 10.1080/02772248.2012.674135.", "ArticleIdList": ["10.1080/02772248.2012.674135"]}, {"Citation": "S\u00e1rpataki O., Sevastre B., Stan R., Olah N.K., Hanganu D., Bedeceu I., Ionescu C., Marcus I. Viscum album, L. Influence on the Antioxidant Enzymes Activity in Ehrlich Tumor Cells In Vivo. Bull. Univ. Agric. Sci. Vet. Med. Cluj-Napoca\u2014Vet. Med. 2014;71:198\u2013203."}, {"Citation": "Holandino C., Melo M.N., Oliveira A.P., da Costa Batista J.V., Capella M.A.M., Garrett R., Grazi M., Ramm H., Dalla Torre C., Schaller G., et al. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts. BMC Complement. Med. Ther. 2020;20:215. doi: 10.1186/s12906-020-02987-4.", "ArticleIdList": ["10.1186/s12906-020-02987-4", "PMC7346636", "32646417"]}, {"Citation": "Yousefvand S.Y., Fathahi F., Hosseini S.M., Urech K., Schaller G. Viscotoxin and lectin content in foliage and fruits of Viscum album L. on the main host trees of Hycanian forests. Sci. Rep. 2002;12:10383. doi: 10.1038/s41598-022-14504-3.", "ArticleIdList": ["10.1038/s41598-022-14504-3", "PMC9209439", "35725801"]}, {"Citation": "Pietrzak W., Nowak R., Olech M. Effect of extraction method on phenolic content and antioxidant activity of mistletoe extracts from Viscum album subsp. abietis. Chem. Pap. 2014;68:976\u2013982. doi: 10.2478/s11696-013-0524-4.", "ArticleIdList": ["10.2478/s11696-013-0524-4"]}, {"Citation": "Papuc C., Crivineanu M., Goran G., Nicorescu V., Durdun N. Free Radicals Scavenging and Antioxidant Activity of European Mistletoe (Viscum album) and European Birthwort (Aristolochia clematitis) Rev. Chim. 2010;61:619\u2013622."}, {"Citation": "Speisky H., Shahidi F., de Camargo A.C., Fuentes J. Revisiting the Oxidation of Flavonoids: Loss, Conservation and Enhancement of Their Antioxidant Properties. Antioxidant. 2022;91:133. doi: 10.3390/antiox11010133.", "ArticleIdList": ["10.3390/antiox11010133", "PMC8772813", "35052636"]}, {"Citation": "Dai J.K., Cao D., Li C.-H. Three new bioactive flavonoids glycosides from Viscum album. Chin. J. Nat. Med. 2019;17:545\u2013550. doi: 10.1016/S1875-5364(19)30076-7.", "ArticleIdList": ["10.1016/S1875-5364(19)30076-7", "31514986"]}, {"Citation": "Orhan D.D., Calis I., Ergun F. Two New Flavonoid Glycosides from Viscum album spp. album. Pharm. Biol. 2002;40:380\u2013383. doi: 10.1076/phbi.40.5.380.8460.", "ArticleIdList": ["10.1076/phbi.40.5.380.8460"]}, {"Citation": "Oremosu A., Edem E.E., Dosumu O.O., Osuntoki A.A. African mistletoe (Loranthaceae) ameliorates cholesterol-induced motor deficit and oxidative stress in adult BALB/c mice. J. Exp. Clin. Anat. 2017;16:121\u2013131."}, {"Citation": "Orhan D.D., Aslan M., Sendogdu N., Ergun F., Yesilada E. Evaluation of the hypoglycemic effect and antioxidant activity of three Viscum album subspecies (European mistletoe) in streptozotocin-diabetic rats. J. Ethnopharmacol. 2005;98:95\u2013102. doi: 10.1016/j.jep.2004.12.033.", "ArticleIdList": ["10.1016/j.jep.2004.12.033", "15763369"]}, {"Citation": "Shahaboddin M.E., Pouramir M., Moghadamnia A.A. Antihyperglycemic and antioxidant activity of Viscum album extract. Afr. J. Pharm. Pharm. 2011;5:432\u2013436. doi: 10.5897/AJPP11.136.", "ArticleIdList": ["10.5897/AJPP11.136"]}, {"Citation": "Elsasser-Beile U., Voss M., Schule R., Wetterauer U. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. J. Clin. Lab. Anal. 2000;14:255\u2013259. doi: 10.1002/1098-2825(20001212)14:6<255::AID-JCLA1>3.0.CO;2-J.", "ArticleIdList": ["10.1002/1098-2825(20001212)14:6<255::AID-JCLA1>3.0.CO;2-J", "PMC6808059", "11138605"]}, {"Citation": "Orhan D.D., Senol F.S., Hosbas S., Orhan I.E. Assessment of cholinesterase and tyrosinase inhibitory and antioxidant properties of Viscum album L. samples collected from different host plants and its two principal substances. Ind. Crops Prod. 2014;62:341\u2013349. doi: 10.1016/j.indcrop.2014.08.044.", "ArticleIdList": ["10.1016/j.indcrop.2014.08.044"]}, {"Citation": "Sengul M., Yildiz H., Gungor N., Cetin B., Eser Z., Ercisli S. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak. J. Pharm. Sci. 2009;22:102\u2013106.", "ArticleIdList": ["19168430"]}, {"Citation": "Delebinski C.I., Twardziok M., Kleinsimon S., Hoff F., Mulson K., Roff J., Jager S., Eggert A., Seifer G. A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo. PLoS ONE. 2015;10:e0133892. doi: 10.1371/journal.pone.0133892.", "ArticleIdList": ["10.1371/journal.pone.0133892", "PMC4526680", "26244918"]}, {"Citation": "Kauczor G., Delebinski C., J\u00e4ger S., Seeger K., Seifert G. Triterpene acid containing Viscum album L. extracts mediate apoptosis in paediatric solid cancer cells. BMC Complement. Altern. Med. 2012;12:P18. doi: 10.1186/1472-6882-12-S1-P18.", "ArticleIdList": ["10.1186/1472-6882-12-S1-P18"]}, {"Citation": "Delebinski C.I., Jaeger S., Kemnitz-assanim K., Henze G., Lode H.N., Seifert G.J. A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia. Cell Prolif. 2012;45:176\u2013181. doi: 10.1111/j.1365-2184.2011.00801.x.", "ArticleIdList": ["10.1111/j.1365-2184.2011.00801.x", "PMC6496480", "22221251"]}, {"Citation": "Kleinsimon S., Longmuss E., Rolff J., Jager S., Debelinski C., Seifert G. GADD45A and CDKN1A Are Involved in Apoptosis and Cell Cycle Modulatory Effects of Viscum TT with Further Inactivation of the STAT3 Pathway. Sci. Rep. 2018;8:5750. doi: 10.1038/s41598-018-24075-x.", "ArticleIdList": ["10.1038/s41598-018-24075-x", "PMC5893628", "29636527"]}, {"Citation": "Nhiem N.X., Kiem P.V., Minh C.V., Kim N., Park S., Lee H.Y., Kim E.S., Kim Y.H., Kim S., Koh Y.-S., et al. Diarylheptanoids and flavonoids from Viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells. J. Nat. Prod. 2013;76:495\u2013502. doi: 10.1021/np300490v.", "ArticleIdList": ["10.1021/np300490v", "23484668"]}, {"Citation": "Kim S.Y., Yang E.J., Son Y.K., Yeo J.-H., Song K.-S. Enhanced anti-oxidative effect of fermented Korean mistletoe is originated from an increase in the contents of caffeic acid and lyoniresinol. Food Funct. 2016;7:2270\u20132277. doi: 10.1039/C6FO00138F.", "ArticleIdList": ["10.1039/C6FO00138F", "27072079"]}, {"Citation": "Panossian A., Kocharian A., Matinian K., Yeo J.-H., Song K.-S. Pharmacological activity of phenylpropanoids of the mistletoe, Viscum album L., host: Pyrus caucasica fed. Phytomedicine. 1998;5:11\u201317. doi: 10.1016/S0944-7113(98)80053-6.", "ArticleIdList": ["10.1016/S0944-7113(98)80053-6", "23195693"]}, {"Citation": "Kleszken E., Purcarea C., Pallag A., Rnaga F., Memete A.R., Miere F., Vicas S.I. Phytochemical Profile and Antioxidant Capacity of Viscum album L. subsp. album and Effects on Its Host Trees. Plants. 2022;11:3021. doi: 10.3390/plants11223021.", "ArticleIdList": ["10.3390/plants11223021", "PMC9694764", "36432750"]}, {"Citation": "Billman G.E. Homeostasis: The Underappreciated and Far Too Often Ignored Central Organizing Principle of Physiology. Front. Physiol. 2020;11:200. doi: 10.3389/fphys.2020.00200.", "ArticleIdList": ["10.3389/fphys.2020.00200", "PMC7076167", "32210840"]}, {"Citation": "Modell H., Cliff W., Michael J., McFarland J., Wenderoth M.P., Wrigt A. A physiologist\u2019s view of homeostasis. Adv. Physiol. Educ. 2015;39:259\u2013266. doi: 10.1152/advan.00107.2015.", "ArticleIdList": ["10.1152/advan.00107.2015", "PMC4669363", "26628646"]}, {"Citation": "Amer B., Johan Juvik O.-L., Francis G.W., Fossen T. Novel GHB-derived natural products from European mistletoe (Viscum album) Pharm. Biol. 2013;51:981\u2013986. doi: 10.3109/13880209.2013.773520.", "ArticleIdList": ["10.3109/13880209.2013.773520", "23734579"]}, {"Citation": "Hostanska K., Hajto T., Fischer J., Mengs U., Weber K., Lentzen H., Seller R. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro. Cancer Detect. Prev. 1999;23:511\u2013523. doi: 10.1046/j.1525-1500.1999.99051.x.", "ArticleIdList": ["10.1046/j.1525-1500.1999.99051.x", "10571662"]}, {"Citation": "Yusuf L., Oladunmoye M.K., Ogundare A.O. In-vivo antibacterial activities of mistletoe (Viscum album) leaves extract growing on cocoa tree in Akure North, Nigeria. Eur. J. Biotechnol. Biosci. 2013;1:37\u201342."}, {"Citation": "Crimeen-Irwin B., Scalzo K., Gloster S., Mottram P.L., Plebanski M. Failure of immune homeostasis\u2014The consequences of under and over reactivity. Curr. Drug Targets Immune Endocr. Metab. Disord. 2005;5:413\u2013422. doi: 10.2174/156800805774912980.", "ArticleIdList": ["10.2174/156800805774912980", "16375694"]}, {"Citation": "Scrivo R., Vasile M., Bartosiewicz I., Valesini G. Inflammation as \u201ccommon soil\u201d of the multifactorial diseases. Autoimmun. Rev. 2011;10:369\u2013374. doi: 10.1016/j.autrev.2010.12.006.", "ArticleIdList": ["10.1016/j.autrev.2010.12.006", "21195808"]}, {"Citation": "Deliorman D., Ergun F., Sener B., Palittapongarnpim P. Evaluation of antimycobacterial activity of Viscum album subspecies. Pharm. Biol. 2001;39:381\u2013383. doi: 10.1076/phbi.39.5.381.5900.", "ArticleIdList": ["10.1076/phbi.39.5.381.5900"]}, {"Citation": "Hussain M.A., Khan M.Q., Hussain N., Habib T. Antibacterial and antifungal potential of leaves and twigs of Viscum album L. J. Med. Plants Res. 2011;5:5545\u20135549."}, {"Citation": "Kenar N., Erdonmez D., Turkmen K.E. Anti-quorum sensing and anti-biofilm activity of Viscum album L. on different pathogenic bacteria. J. Biotechnol. 2016;1000:1000. doi: 10.1016/j.jbiotec.2016.05.138.", "ArticleIdList": ["10.1016/j.jbiotec.2016.05.138"]}, {"Citation": "Oguntoye S.O., Olatunji G.A., Kolawole O.M., Enonbun K.I. Phytochemical screening and antibacterial activity of Viscum album (mistletoe) extracts. Plant Sci. Res. 2008;1:44\u201346."}, {"Citation": "Erturk \u00d6., Kati H., Yayli N., Demirbag Z. Antimicrobial activity of Viscum album L. subsp. abietis (Wiesb) Turk. J. Biol. 2003;27:255\u2013258."}, {"Citation": "Kusi M., Shrestha K., Malla R. Study on phytochemical, antibacterial, antioxidant and toxicity profile of Viscum album Linn associated with Acacia catechu. Nepal J. Biotechnol. 2015;3:60\u201365. doi: 10.3126/njb.v3i1.14234.", "ArticleIdList": ["10.3126/njb.v3i1.14234"]}, {"Citation": "Turker A.U., Yildirim A.B., Karakas F.P. Antitumor and antibacterial activities of Viscum album L. grown on different host trees. Spat DD. 2012;2:229\u2013236. doi: 10.5455/spatula.20121224052924.", "ArticleIdList": ["10.5455/spatula.20121224052924"]}, {"Citation": "WHO  New release. SEARO. 4 February 2022. New Delhi. See also Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Pi\u00f1eros, M. et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020.  [(accessed on 28 February 2021)].  Available online:  https://gco.iarc.fr/today."}, {"Citation": "Song K.S., Yoon D.K., Bum K.J. Chemical Pleurodesis Using Doxycycline and Viscum album extract. J. Chest Surg. 2017;50:2765\u20132786. doi: 10.5090/kjtcs.2017.50.4.281.", "ArticleIdList": ["10.5090/kjtcs.2017.50.4.281", "PMC5548205", "28795034"]}, {"Citation": "Lu H., Ouyang W., Huang C. Inflammation, a Key Event in Cancer Development. Mol. Cancer Res. 2006;4:221\u2013233. doi: 10.1158/1541-7786.MCR-05-0261.", "ArticleIdList": ["10.1158/1541-7786.MCR-05-0261", "16603636"]}, {"Citation": "Zhao H., Wu L., Yan G., Chen Y., Zhou M., Wu Y., Li Y. Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal Transduct. Target. Ther. 2021;6:263. doi: 10.1038/s41392-021-00658-5.", "ArticleIdList": ["10.1038/s41392-021-00658-5", "PMC8273155", "34248142"]}, {"Citation": "Philip M., Rowley D.A., Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol. 2004;14:433. doi: 10.1016/j.semcancer.2004.06.006.", "ArticleIdList": ["10.1016/j.semcancer.2004.06.006", "15489136"]}, {"Citation": "Okada F. Inflammation and free radicals in tumor development and progression. Redox Rep. 2002;7:357. doi: 10.1179/135100002125001135.", "ArticleIdList": ["10.1179/135100002125001135", "12625943"]}, {"Citation": "Balkwill F., Mantovani A. Inflammation and cancer: Back to Virchow? Lancet. 2001;357:539. doi: 10.1016/S0140-6736(00)04046-0.", "ArticleIdList": ["10.1016/S0140-6736(00)04046-0", "11229684"]}, {"Citation": "Nathan C. Points of control in inflammation. Nature. 2002;420:846\u2013852. doi: 10.1038/nature01320.", "ArticleIdList": ["10.1038/nature01320", "12490957"]}, {"Citation": "Khusmurrokhma G., Wati F.F. Tumor-promoting inflammation in lung cancer: A literature review. Ann. Med. Surg. 2022;79:104022.", "ArticleIdList": ["PMC9289429", "35860063"]}, {"Citation": "Multhoff G., Molls M., Randons J. Chronic Inflammation in Cancer Development. Front. Immunol. 2012;2:98. doi: 10.3389/fimmu.2011.00098.", "ArticleIdList": ["10.3389/fimmu.2011.00098", "PMC3342348", "22566887"]}, {"Citation": "Alam M.M., Rahman T., Afroz Z., Chakraborty P.A., Wahab A., Zaman S., Hawlader M.D.H. Quality of Life (QoL) of cancer patients and its association with nutritional and performance status: A pilot study. Heliyon. 2020;6:e05250. doi: 10.1016/j.heliyon.2020.e05250.", "ArticleIdList": ["10.1016/j.heliyon.2020.e05250", "PMC7586095", "33134577"]}, {"Citation": "Yang C.R., Hsieh S.L., Ho F.M., Lin W.W. Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-nB-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression. J. Immunol. 2005;174:1647. doi: 10.4049/jimmunol.174.3.1647.", "ArticleIdList": ["10.4049/jimmunol.174.3.1647", "15661928"]}, {"Citation": "Tabiasco J., Pont F., Fourni\u00e9 J.-J., Vercellone A. Mistletoe viscotoxins increase natural killer cell mediated cytotoxicity. Eur. J. Biochem. 2002;269:2591\u20132600. doi: 10.1046/j.1432-1033.2002.02932.x.", "ArticleIdList": ["10.1046/j.1432-1033.2002.02932.x", "12027898"]}, {"Citation": "Zalba S., ten Hagen T.L.M. Cell membrane modulation as adjuvant in cancer therapy. Cancer Treat. Rev. 2017;52:48\u201357. doi: 10.1016/j.ctrv.2016.10.008.", "ArticleIdList": ["10.1016/j.ctrv.2016.10.008", "PMC5195909", "27889637"]}, {"Citation": "Escriba P.V. Membrane-lipid therapy: A new approach on molecular medicine. Trends Mol. Med. 2006;12:34\u201335. doi: 10.1016/j.molmed.2005.11.004.", "ArticleIdList": ["10.1016/j.molmed.2005.11.004", "16325472"]}, {"Citation": "Chromanska A., Chwilkowska A., Kulbaka J., Baczynska D., Rembialkowska N., Szewczyk A., Michel O., Gajewska-Naryniecka A., Przystupski D., Saczko J. Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy. Molecules. 2021;26:1850. doi: 10.3390/molecules26071850.", "ArticleIdList": ["10.3390/molecules26071850", "PMC8037978", "33806009"]}, {"Citation": "Maier G., Fiebig H.H. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anticancer Drugs. 2002;13:373\u2013379. doi: 10.1097/00001813-200204000-00006.", "ArticleIdList": ["10.1097/00001813-200204000-00006", "11984083"]}, {"Citation": "Melzer J., Iten F., Hostanska K., Saller R. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch Komplementmed. 2009;16:217\u2013226.", "ArticleIdList": ["19729932"]}, {"Citation": "Rib\u00e9reau-Gayon G., Jung M.L., Baudino S., Sall\u00e9 G., Beck J.P. Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells. Experientia. 1986;42:594\u2013599. doi: 10.1007/BF01955552.", "ArticleIdList": ["10.1007/BF01955552", "3013672"]}, {"Citation": "Chai Y., Zhao M. ITRAQ-Based Quantitative Proteomic Analysis of the Inhibitory Effects of Polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 Cells. Sci. Rep. 2017;4:4596.", "ArticleIdList": ["PMC5496916", "28676664"]}, {"Citation": "Vergara-Barber\u00e0n M., Lerma-Garc\u00eca M., Nicoletti M., Sim\u00f2-Alfonso E.F., Herero-Martinez J.M., Fasoli E., Rigetti P.G. Proteomic fingerprint of mistletoe (Viscum album L.) via recombinatorial peptide ligand libraries and mass spectrometry analysis. J. Proteom. 2017;164:52\u201358. doi: 10.1016/j.jprot.2017.05.025.", "ArticleIdList": ["10.1016/j.jprot.2017.05.025", "28571969"]}, {"Citation": "Tsekouras V., Mavrikon M., Vlachakis D., Makridakis M., Stroggilos R., Zoidakis J., Termentzi A., Moschopouou G., Kintzios S. Proteome analysis of leaf, stem and callus in Viscum album and identification of lectins and viscotoxins with bioactive properties. Plant Cell Tissue Organ Cult. 2020;141:167\u2013178. doi: 10.1007/s11240-020-01777-7.", "ArticleIdList": ["10.1007/s11240-020-01777-7"]}, {"Citation": "Zarkovi\u0107 T., Kalisnik I., Loncari\u0107 S., Borovic S., Mang S., Kissel D., Konitzer M., Jurin M., Grainza S. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10. Cancer Biother. Radiopharm. 1998;13:121\u2013131. doi: 10.1089/cbr.1998.13.121.", "ArticleIdList": ["10.1089/cbr.1998.13.121", "10850348"]}, {"Citation": "Melo M.N.d.O., Ochioni A.C., Zancan P., Oliveira A.P., Grazi M., Garrett R., Holandino C., Baumgartner S. Viscum album mother tinctures: Harvest conditions and host trees influence the plant metabolome and the glycolytic pathway of breast cancer cells. Front. Pharmacol. 2022;13:1027931. doi: 10.3389/fphar.2022.1027931.", "ArticleIdList": ["10.3389/fphar.2022.1027931", "PMC9662615", "36386174"]}, {"Citation": "Zarkovic N. Adjuvant Cancer Biotherapy by Viscum album Extract Isorel: Overview of Evidence Based Medicine Findings. Coll. Antropol. 2005;39:701\u2013708.", "ArticleIdList": ["26898069"]}, {"Citation": "Dairo G., Ilesanmi A., Balogun T., Ward M., Soendergaard M., Determan J. Biological and Medicinal Chemistry. Cambridge Open Engage; Cambridge, UK: 2022. Computational Evaluation of Bioactive Compounds from Viscum album (mistletoe) as inhibitors of 63 for Pancreatic Cancer treatment. ChemRXiV.", "ArticleIdList": ["36935102"]}, {"Citation": "Coulon A., Berkane E.-B., Sautereau A.H., Urech K., Rouge P., Lopez A. Mode of membrane interaction of natural cysteine-rich peptide: Viscotoxin A3. Biochim. Biophys. Acta. 2002;1559:145\u2013158. doi: 10.1016/S0005-2736(01)00446-1.", "ArticleIdList": ["10.1016/S0005-2736(01)00446-1", "11853681"]}, {"Citation": "Coulon A., Mosbah A., Lopez A., Sautereau A.-M., Schaller G., Urech K., Rang\u00e9 P., Darbon H. Comparative membrane interaction study of viscotoxins A3, A2, and B from mistletoe (Viscum album) and connection with their structures. Biochem. J. 2003;374:71\u201378. doi: 10.1042/bj20030488.", "ArticleIdList": ["10.1042/bj20030488", "PMC1223566", "12733989"]}, {"Citation": "Baek J.-H., Jeon Y., Han K.-W., Jung D.H., Kim K.O. Effect of mistletoe extract on tumor response in neoadjuvant chemotherapy for rectal cancer: A cohort study. World J. Surg. Oncol. 2021;19:18. doi: 10.1186/s12957-021-02293-4.", "ArticleIdList": ["10.1186/s12957-021-02293-4", "PMC8207698", "34130688"]}, {"Citation": "Choi H.J., Park S., Choi Y.N., Kim S.-D., Kwag E.-B., Song S.-Y., Park J.H., Kim J.K., Seo C., Choi J.J., et al. Selective Immune Modulating Activities of Viscum album and Its Components; A Possibility of Therapeutics on Skin Rash Induced by EGFR Inhibitors. Integr. Cancer Ther. 2022;21:15347354221118332. doi: 10.1177/15347354221118332.", "ArticleIdList": ["10.1177/15347354221118332", "PMC9513566", "36154312"]}, {"Citation": "Bocci V. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review. J. Biol. Regul. Homeost. Agents. 1993;7:1\u20136.", "ArticleIdList": ["8346712"]}, {"Citation": "Braedel-Ruoff S. Immunomodulatory effects of Viscum album extracts on natural killer cells: Review of clinical trials. Complement. Med. Res. 2010;17:63\u201373. doi: 10.1159/000288702.", "ArticleIdList": ["10.1159/000288702", "20484913"]}, {"Citation": "Chernyshov V.P., Omelchenko L.I., Heusser P., Chernyshova L.I., Vodyanik M.A., Vykhovanets E.V., Galazyk L.V., Pochinov T.V., Goviday N.V., Gumenyuk K., et al. Immunomodulatory actions of Viscum album (Iscador) in children with recurrent respiratory disease as a result of the Chernobyl nuclear accident. Complement. Ther. Med. 1997;5:141\u2013146. doi: 10.1016/S0965-2299(97)80056-8.", "ArticleIdList": ["10.1016/S0965-2299(97)80056-8", "11317168"]}, {"Citation": "Stan R.L., Hangan A.C., Dican L., Sevastre B., Hanganu D., Catoi C., Sarpataki O., Ionescu C.M. Comparative study concerning mistletoe viscotoxins antitumor activity. Acta Biol. Hung. 2013;64:279\u2013288. doi: 10.1556/ABiol.64.2013.3.2.", "ArticleIdList": ["10.1556/ABiol.64.2013.3.2", "24013890"]}, {"Citation": "Rocha M.S., Batista J.V.C., Melo M.N.O., de Campos V.E.B., Toledo A.L.M.M., Oliveira A.P., Picciani P.M., Baumgartner S., Holandino C. Thermoresponsive Hydrogel Containing Viscum album Extract for Topic and Transdermal Use: Development, Stability and Cytotoxicity Activity. Farmaceutica. 2022;14:27.", "ArticleIdList": ["PMC8780802", "35056932"]}, {"Citation": "Zuzak T.J., Wasmuth A., Bernitzki S., Schwermer M., Laugher A. Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series. Complement. Ther. Med. 2018;40:198\u2013202. doi: 10.1016/j.ctim.2018.01.002.", "ArticleIdList": ["10.1016/j.ctim.2018.01.002", "30219449"]}, {"Citation": "Kienle S.G., Grungel R., Keine H. Safety of higher-dosage of Viscum album L. in animals and humans\u2014Systematic review of immune changes and safety parameters. BMC Complement. Altern. Med. 2011;11:72. doi: 10.1186/1472-6882-11-72.", "ArticleIdList": ["10.1186/1472-6882-11-72", "PMC3180269", "21871125"]}, {"Citation": "Schad F., Thronicke A. Safety of Combined Targeted and Helixor\u00ae Viscum album L. Therapy in Breast and Gynecological Cancer Patients, a Real-World Data Study. Int. J. Environ. Res. Public Health. 2023;20:2565. doi: 10.3390/ijerph20032565.", "ArticleIdList": ["10.3390/ijerph20032565", "PMC9916034", "36767928"]}, {"Citation": "Grossarth-Maticek R., Kiene H., Baumgartner S.M., Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern. Ther. Health Med. 2001;7:57\u201366.", "ArticleIdList": ["11347286"]}, {"Citation": "Ostermann T., Appelbaum S., Poier D., Boehm K., Raak C., Bussing A. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings. Complement. Med. Res. 2020;27:260\u2013271. doi: 10.1159/000505202.", "ArticleIdList": ["10.1159/000505202", "31927541"]}, {"Citation": "Matthes H., Friedel W.E., Bock P.-R., Zancher K.S. Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer. Curr. Mol. Med. 2010;10:434\u2013439. doi: 10.2174/156652410791317057.", "ArticleIdList": ["10.2174/156652410791317057", "20455850"]}, {"Citation": "Enesel M.B., Acalovschi I., Grosu V., Sbarcea A., Rusu C., Dobre A., Weiss T., Zarkovic W. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients. Anticancer Res. 2005;25:4583\u20134590.", "ArticleIdList": ["16334146"]}, {"Citation": "Anonimous . A Prospective Dose Finding Study of Iscador Infusion. HaEmek Medical Center; Afula, Israel: 2020."}, {"Citation": "Wode K., Nordberg J.H., Kienle G., Elander N.O., Bernharsoon B.-M., Sunde B., Sharp L., Henriksson R., Fransson P. Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: Study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL) Trial. 2020;21:783. doi: 10.1186/s13063-020-04581-y.", "ArticleIdList": ["10.1186/s13063-020-04581-y", "PMC7488501", "32917288"]}, {"Citation": "Schad F., Thronicke A., Steele M.L., Merkle A., Matthes B., Grah C., Matthes H. Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis. PLoS ONE. 2018;13:e0203058. doi: 10.1371/journal.pone.0203058.", "ArticleIdList": ["10.1371/journal.pone.0203058", "PMC6110500", "30148853"]}, {"Citation": "Thronicke A., Schad F., Debus M., Graboski J., Soldner G. Viscum album L.-Therapy in Oncology: An Update of Current Evidence. Complement. Med. Res. 2022;29:362\u2013368. doi: 10.1159/000524184.", "ArticleIdList": ["10.1159/000524184", "35325897"]}, {"Citation": "Bryant S., Dubcan L., Feder G., Huntley A. A pilot study of the mistletoe and breast cancer (MAB) trial: A protocol for a randomised double-blind controlled trial. Pilot Feasibility Stud. 2022;8:78. doi: 10.1186/s40814-022-01036-w.", "ArticleIdList": ["10.1186/s40814-022-01036-w", "PMC8985298", "35387677"]}, {"Citation": "Steele M., Axtner J., Happe A., Kroz M., Matthes H., Schad F. Use and Safety of Intratumoral Application of European Mistletoe (Viscum album L.) Preparation on Oncology. Integr. Cancer Ther. 2014;14:140\u2013148. doi: 10.1177/1534735414563977.", "ArticleIdList": ["10.1177/1534735414563977", "25552476"]}, {"Citation": "Zarkovic N., Vukovic T., Loncaric I., Zarkovic S., Borovic S., Cipak A., Sabolovic S., Konitzer M., Morig S. An Overview on Anticancer Activities of the Viscum Album Extract Isorel\u00ae. Cancer Biother. Radiopharm. 2001;16:55\u201362.", "ArticleIdList": ["11279798"]}, {"Citation": "Lee Y.-G., Jung I., Koo D.-H., Kang D.-Y., Oh T.Y., Oh S., Lee S.-S. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer. Support Care Cancer. 2019;27:1945\u20131949. doi: 10.1007/s00520-018-4455-z.", "ArticleIdList": ["10.1007/s00520-018-4455-z", "30218188"]}, {"Citation": "Kim C.-W., Kim J.-S., Lee A.-H., Kim Y.-S. Viscum album extract (Helixor-M) treatment for thoracic duct injury after modified radical neck dissection: A case report. Gland Surg. 2021;10:832\u2013836. doi: 10.21037/gs-20-629.", "ArticleIdList": ["10.21037/gs-20-629", "PMC7944075", "33708565"]}, {"Citation": "Rostok M. Mistletoe in the treatment of cancer. Bundesgesundheitsblatt Gesundh. Gesundh. 2020;63:535\u2013540.", "ArticleIdList": ["32211937"]}, {"Citation": "Staupe H., Buentzel J., Keinki C., Buentzel J., Haiebner J. Systematic analysis of mistletoe prescriptions in clinical studies. J. Cancer Res. Clin. Oncol. 2022 doi: 10.1007/s00432-022-04511-2.", "ArticleIdList": ["10.1007/s00432-022-04511-2", "PMC10356894", "36481925"]}, {"Citation": "Young J.P., Sang K.M., Jang Y.K., Yun S.S., Park S.C. Retroperitoneal Viscum album extract instillation in patients with a large amount of drainage after kidney transplantation. Ann. Surg. Treat. Res. 2021;101:368\u2013373.", "ArticleIdList": ["PMC8651988", "34934764"]}, {"Citation": "Kelter G., Jorg M., Schierholz H., Fiebig H.H. Cytotoxic Activity and Absence of Tumor Growth Stimulation of Standardized Mistletoe Extracts in Human Tumor Models In Vitro. Anticancer Res. 2007;27:223\u2013234.", "ArticleIdList": ["17352237"]}, {"Citation": "Fellmer K.E. A clinical trial of Iscador: Follow-up treatment of irradiated genital carcinomata for the prevention of recurrences. Br. Homeopat. J. 1968;57:43\u201347. doi: 10.1016/S0007-0785(68)80049-3.", "ArticleIdList": ["10.1016/S0007-0785(68)80049-3"]}, {"Citation": "Montero G.D., Valladares M.B., Tornes C. Tratamiento homeop\u00e1tico y convencional de la hipertensi\u00f3n arterial. Rev. M\u00e9d. Homeopat. 2016;9:53\u201358. doi: 10.1016/j.homeo.2016.07.005.", "ArticleIdList": ["10.1016/j.homeo.2016.07.005"]}, {"Citation": "Oberbaum M., Yaniv I., Ben-Gal Y., Stein J., Ben-Zvi N., Frredman L.S., Branski D. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer. 2001;92:684\u2013690. doi: 10.1002/1097-0142(20010801)92:3<684::AID-CNCR1371>3.0.CO;2-#.", "ArticleIdList": ["10.1002/1097-0142(20010801)92:3<684::AID-CNCR1371>3.0.CO;2-#", "11505416"]}, {"Citation": "Bonamin L., Cardoso T.N., Carvalho A.C., Amaral J. A systematic review about animal models in homeopathic research: The last five years of PubMed indexed papers. Int. J. High Dilution Res. 2015;14:45. doi: 10.51910/ijhdr.v14i2.783.", "ArticleIdList": ["10.51910/ijhdr.v14i2.783"]}, {"Citation": "Christen-Clottu O., Klocke P., Burger D., Straub R., Gerber V. Treatment of clinically diagnosed equine. J. Vet. Intern. Med. 2010;24:1483\u20131489. doi: 10.1111/j.1939-1676.2010.0597.x.", "ArticleIdList": ["10.1111/j.1939-1676.2010.0597.x", "21039860"]}, {"Citation": "Carvalho A., Valle A.C.V. Treatment of Alimentary Lymphoma in Cat (Felis catus) by Injectable Homeopathy\u2014Case Report. Integr. J. Vet. Biosc. 2021;5:19."}, {"Citation": "Carvalho A.C., Porto E., Bonamin L. Canine neurofibrosarcoma treatment with Viscum album in serial dilutions. Homeopathy. 2013;12:106."}, {"Citation": "Valle A.C.V., de Carvalho A.C. Viscum album in Veterinary Medicine. IJSR. 2021;10:42\u201349."}, {"Citation": "Lopes D.F., Valle A.C.V., Sibata M.N. Treatment and staging of canine lymphoma with ultra-diluted Viscum album and homeopathic associations: Case report. Rev. Educ. Contin. Med. Vet. Zootecn. CRMV-SP. 2018;16:89\u201390."}, {"Citation": "Graf R., Gruntzig K., Boo G., Hassig R., Axhauser K.W., Fabrikant S., Welle M., Meier D., Guscett F., Folkers G., et al. Swiss feline cancer registry 1965\u20132008: The influence of sex, breed and age on tumour types and tumour locations. J. Comp. Pathol. 2016;154:195\u2013210. doi: 10.1016/j.jcpa.2016.01.008.", "ArticleIdList": ["10.1016/j.jcpa.2016.01.008", "26922257"]}, {"Citation": "Bonamin L.V., Carvalho A., Waisse S. Viscum album (L.) in experimental animal tumours: A meta-analysis. Exp. Ther. Med. 2017;13:2723\u20132740. doi: 10.3892/etm.2017.4372.", "ArticleIdList": ["10.3892/etm.2017.4372", "PMC5457804", "28596809"]}, {"Citation": "Biegel U., von Bodungen U., Ruess K., Reif M., Knauf Y., Stratmann N. Mistletoe in adjuvant cancer treatment of companion animals. Planta Med. 2019;85:1392."}, {"Citation": "Biegel U., Ruess-Melzer K., Klocke P. Orally administered Viscum album Quercus dilutions in the therapy of feline fibrosarcoma in cats. Phytomedicine. 2011;18:24. doi: 10.1016/j.phymed.2011.09.057.", "ArticleIdList": ["10.1016/j.phymed.2011.09.057"]}, {"Citation": "Valle A.C.V., Andrade R.V., Sibata M.N., Carvalho A.C. Ultradiluted Viscum album in the Treatment of Melanoma in a Dog (Canis familiaris)\u2014Case Report. Homeopathy. 2020;109:1\u201318.", "ArticleIdList": ["0"]}, {"Citation": "Valle A.C.V., Sibata M.N., Andrade R.V., Carvalho A.C. Homeopathy for the Treatment of Transmissible Venereal Tumor (TVT) in a Mixed-Breed Female Dog. Adv. Complement. Altern. Med. 2019;5:422\u2013424."}, {"Citation": "Wright A., Watanabe R., Koehler J.W. European Mistletoe (Viscum album) Extract Is Cytotoxic to Canine High-Grade Astrocytoma Cells In Vitro and Has Additive Effects with Mebendazole. Vet. Sci. 2022;9:31. doi: 10.3390/vetsci9010031.", "ArticleIdList": ["10.3390/vetsci9010031", "PMC8782024", "35051115"]}, {"Citation": "Heidner G.L., Kornegay J.N., Page R.L., Dodge R.K., Thrall D.E. Analysis of survival in a retrospective study of 86 dogs with brain tumors. J. Vet. Intern. Med. 1991;5:219\u2013226. doi: 10.1111/j.1939-1676.1991.tb00952.x.", "ArticleIdList": ["10.1111/j.1939-1676.1991.tb00952.x", "1941756"]}, {"Citation": "Hawu O., Ravhuhali K.E., Musekwa M.G., Sipango N., Mudau H.S., Mokoboki K.H., Moyo B. Utilization of the Viscum Species for Diet and Medicinal Purposes in Ruminants: A Review. Animals. 2022;12:2569. doi: 10.3390/ani12192569.", "ArticleIdList": ["10.3390/ani12192569", "PMC9559218", "36230309"]}, {"Citation": "Blostin R., Faivre C. B\u00e9n\u00e9fices du gui ferment\u00e9 chez le chat apr\u00e8s ex\u00e9r\u00e8se de fibrosarcome: R\u00e9sultats d\u2019une \u00e9tude pr\u00e9liminaire. Phytotherapie. 2008;6:352\u2013358. doi: 10.1007/s10298-008-0348-5.", "ArticleIdList": ["10.1007/s10298-008-0348-5"]}, {"Citation": "Roy S. Pharmacokinetics of homeopathis mother tincture Viscum album after intradermal administration. Clin. Exp. Homeopath. 2019;6:20\u2013222."}, {"Citation": "Valle A.C.V., Aguiar L.R., Brunel H.S.S., Malard P.F., Andrade R.V., Villaroel C.L.P., Andrade R.V. Homeopathic Viscum album (10-3) is more cytotoxic in vitro Culture of Human Breast Cancer Cell Line to Human Mesenchymal Stem Cell. Int. J. High Dilution Res. 2020;19:25\u201334. doi: 10.51910/ijhdr.v19i4.1036.", "ArticleIdList": ["10.51910/ijhdr.v19i4.1036"]}, {"Citation": "Valle A.C.V., Brunel H.S.S., Malard P.F., Villaroel C.L., Andrade R.V. Homeopathic Viscum album at Potencies D3 and 200CH Presents Cytokine Modulatory Effect Produced by in vitro Culture of Mesenchymal Stem Cells. Curr. Res. Complement. Altern. Med. 2022;6:155."}, {"Citation": "Valle A.C.V., Aguiar R.L., Brunel H.S.S., Malard P.F., Andrade R.V. Osteosarcoma cells are inhibited by homoeopathic Viscum album. J. Integr. Stand. Homoeopath. 2020;3:59\u201363. doi: 10.25259/JISH_32_2020.", "ArticleIdList": ["10.25259/JISH_32_2020"]}, {"Citation": "Hollandino C., Melo M., da Costa Batista I., da Valga F., da Costa Batista J.V., Capella M.A.M., Garrett R., Grazi M., Weissenstein U., Baumgartner S. Viscum album homeopathic tinctures: Phytochemical Profile and Antiproliferative Activity. Int. J. High Dilution Res. 2018;17:4\u20138."}, {"Citation": "Karagoz A., Onay E., Arda N., Kuru A. Antiviral potency of mistletoe (Viscum album ssp. album) extracts against human parainfluenza Virus type 2 in Vero cells. Phytother. Res. 2003;17:560\u2013562. doi: 10.1002/ptr.1163.", "ArticleIdList": ["10.1002/ptr.1163", "12749000"]}, {"Citation": "Valle A.C.V., Carvalho A.C. Ultra-diluted Viscum album in the treatment of cutaneous melanoma in a dog (Canis familiaris). Case report. Paripex Indian J. Res. 2021;10:1\u20134."}, {"Citation": "Mellor D: Mistletoe in homoeopathic cancer treatment. Prof. Nurse. 1989;4:605\u2013607.", "ArticleIdList": ["2813459"]}, {"Citation": "Matthes H., Thronicke A., Ralf-Dieter Hofheinz R.-D., Baars E., Martin D., Huber R., Breitkreuz T., Bar-Sela G., Glum D., Shad F. Statement to an Insufficient Systematic Review on Viscum album L. Therapy. Evid.-Based Complement. Altern. Med. 2020;2020:7091039. doi: 10.1155/2020/7091039.", "ArticleIdList": ["10.1155/2020/7091039", "PMC7049420", "32148549"]}, {"Citation": "Molassiotis A., Fernandez-Ortega P., Pud D., Odsen G., Scott J.A., Panteli V., Margulie S.A., Browall M., Magri M., Selvikprova S., et al. Use of complementary and alternative medicine in cancer patients: A European survey. Ann. Oncol. 2005;16:655\u2013663. doi: 10.1093/annonc/mdi110.", "ArticleIdList": ["10.1093/annonc/mdi110", "15699021"]}, {"Citation": "Bar-Sela G., Wollner M., Hammer L., Agbarya A., Dudnik E., Haim N. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study. Eur. J. Cancer. 2013;49:1058\u20131064. doi: 10.1016/j.ejca.2012.11.007.", "ArticleIdList": ["10.1016/j.ejca.2012.11.007", "23218588"]}, {"Citation": "Casetti F., Rafei-Shamsabadi D., M\u00fcller S. Grade II-anaphylaxis after subcutaneous injection of mistletoe extract. Contact Dermat. 2021;85:462\u2013465. doi: 10.1111/cod.13880.", "ArticleIdList": ["10.1111/cod.13880", "33963569"]}, {"Citation": "Stoss M., Van Wely M., Musielsky H., Gorter R.W. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks. Arzneimittelforschung. 1999;49:366\u2013373. doi: 10.1055/s-0031-1300428.", "ArticleIdList": ["10.1055/s-0031-1300428", "10337457"]}, {"Citation": "Finall A.I., McIntosh S.A., Thompson W.D. Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract. BMJ. 2006;333:1293. doi: 10.1136/bmj.39044.460023.BE.", "ArticleIdList": ["10.1136/bmj.39044.460023.BE", "PMC1761174", "17185712"]}, {"Citation": "Steele M.L., Axtner J., Happe A., Kroz M., Matthes H., Schad N. Adverse drug reactions and expected effects to therapy with subcutaneous mistletoe extracts (Viscum album L.) in cancer patients. Evid. Based Complement. Altern. Med. 2014;2014:724258. doi: 10.1155/2014/724258.", "ArticleIdList": ["10.1155/2014/724258", "PMC3929984", "24672577"]}, {"Citation": "Schl\u00e4ppi M., Ewald C., Kuehn J.J., Weinert T., Thuber R. Fever therapy with intravenously applied mistletoe extracts for cancer patients: A retrospective study. Integr. Cancer Ther. 2017;16:479\u2013484. doi: 10.1177/1534735416658121.", "ArticleIdList": ["10.1177/1534735416658121", "PMC5739132", "27387685"]}, {"Citation": "Hutt N., Kopferrschitt-Kobler M.C., Cabalion J., Purohit A., Alt M., Pauli G. Anaphylactic reaction after therapeutic injection of mistletoe (Viscum album L.) Allergol. Immunopathol. 2001;29:201\u2013203. doi: 10.1016/S0301-0546(01)79056-8.", "ArticleIdList": ["10.1016/S0301-0546(01)79056-8", "11720654"]}, {"Citation": "Stein G.M., Pf\u00fcller U., Schietzel M. Viscotoxins-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes. Anticancer Res. 1999;19:2925\u20132928.", "ArticleIdList": ["10652574"]}, {"Citation": "Giudici M., Pascual R., Canal L., Pfuller K., Pfuller U., Villalain J. Interaction of Viscotoxins A3 and B with Membrane Model Systems: Implications to their mechanism of action. Biophys. J. 2003;85:971\u2013981. doi: 10.1016/S0006-3495(03)74536-6.", "ArticleIdList": ["10.1016/S0006-3495(03)74536-6", "PMC1303218", "12885644"]}, {"Citation": "Johannes L., Jacob R., Leffer H. Galectins at a Glance. J. Cell Sci. 2018;131:jcs208884. doi: 10.1242/jcs.208884.", "ArticleIdList": ["10.1242/jcs.208884", "29717004"]}, {"Citation": "Gengebach B.B., Linda L.K., Buyel J.F., Muscen C.R., Melmer G., Lentzen H., Buhrmann J., Buyel J.F. Comparison of microbial and transient expression (tobacco plants and plant-cell) for production and purification of the anticancer mistletoe lectin viscumin of the anticancer mistletoe Viscumin. Biotechnol. Bioeng. 2019;116:2236\u20132249. doi: 10.1002/bit.27076.", "ArticleIdList": ["10.1002/bit.27076", "PMC6772165", "31140580"]}, {"Citation": "Sholova N., Bovm N., Maltseva D., Polyakova S., Sablina M., Niwa H., Zakharova G., Raygorodskaya M., Bufeeva L., Belyi Y., et al. Specificity of viscumin reversed. As probed with a printed glycan array. Biochimie. 2022;202:94\u2013102. doi: 10.1016/j.biochi.2022.08.009.", "ArticleIdList": ["10.1016/j.biochi.2022.08.009", "35988841"]}, {"Citation": "Schotterl S., Hubner M., Armento A., Vininga V., Wirsik N.M., Bernatz S., Lentzen H., Mittelbronm M., Naumann U. Viscumins functionally modulate cell mobility-associated gene expression. Int. J. Oncol. 2017;50:684\u2013696. doi: 10.3892/ijo.2017.3838.", "ArticleIdList": ["10.3892/ijo.2017.3838", "28101577"]}, {"Citation": "Sch\u00f6ffski P., Riggert S., Fumoleau P., Campone M., Bolte O., Marreaud S., Lacombe D., Baron B., Herold M., Zwierzina H., et al. Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: A study of the European Organization for Research and Treatment of Cancer New Drug Development Group. Ann. Oncol. 2004;15:1816\u20131824. doi: 10.1093/annonc/mdh469.", "ArticleIdList": ["10.1093/annonc/mdh469", "15550588"]}, {"Citation": "Fritz P., Seizer-Schmidt R., M\u00fcrdter T.E., Kroemer H.K., Aulitzky W., Andr\u00e9 S., Gabius H.J., Friedel G., Toomas H., Siegel I. Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: Is there any prognostic relevance? Acta Histochem. 1999;101:239\u2013253. doi: 10.1016/S0065-1281(99)80025-7.", "ArticleIdList": ["10.1016/S0065-1281(99)80025-7", "10443287"]}, {"Citation": "Gabias H.-J. Probing the cons and the pros of lectin-induced immunomodulation: Case studies of the mistletoe lectin and galectin-1. Biochimie. 2001;83:659\u2013666. doi: 10.1016/S0300-9084(01)01311-6.", "ArticleIdList": ["10.1016/S0300-9084(01)01311-6", "11522395"]}, {"Citation": "Lenartz D., Stoffel B., Menzel J., Beuth J. Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destruction therapy in glioma patients. Anticancer Res. 1996;16:3799\u20133802.", "ArticleIdList": ["9042260"]}, {"Citation": "Hostanska K., Hajto T., Weber K., Fischer J., Lentzen H., Sutterlin B., Saller R. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Nat. Immun. 1996;15:295\u2013311.", "ArticleIdList": ["9523281"]}, {"Citation": "Chou F.-C., Chen H.-Y., Kuo C.-C., Sytwu H.-K. Role of Galectins in Tumors and in Clinical Immunotherapy. Int. J. Mol. Sci. 2018;19:430. doi: 10.3390/ijms19020430.", "ArticleIdList": ["10.3390/ijms19020430", "PMC5855652", "29389859"]}, {"Citation": "Rabinovich G.A., Toscano M.A. Turning \u201csweet\u201d immunology: Galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2003;9:338\u2013352.", "ArticleIdList": ["19365409"]}, {"Citation": "Jing Hong J., Meng L., Yu P., Zhou C., Yu Z., Zhao Y. Novel drug isolated from mistletoe (1 E,4 E)-1,7-bis(4-hydroxyphenyl)hepta-1,4-dien-3-one for potential treatment of various cancers: Synthesis, pharmacokinetics and pharmacodynamics. RCS Adv. 2020;10:27794\u201327804. doi: 10.1039/D0RA03674A.", "ArticleIdList": ["10.1039/D0RA03674A", "PMC9055608", "35516963"]}, {"Citation": "Byeon S.E., Lee J., Yu T., Cho J.-Y. Extracellular Signal-Regulated Kinase Is a Major Enzyme in Korean Lectin-Mediated Regulation of Macrophage Functions. Biomol. Ther. 2009;17:293\u2013298. doi: 10.4062/biomolther.2009.17.3.293.", "ArticleIdList": ["10.4062/biomolther.2009.17.3.293"]}, {"Citation": "Korcan S.E., Cankaya N., Arzarkhan S.Y., Bulduk I., Karaaslan E.C., Kargioglu M., Konik M., Guvercin G. Determination of Antioxidant Activities of Viscum album L.: First Report on Interaction of Phenolics with Survinin Protein using in Silico Analysis. ChemistrySelect. 2023;8:e202300130. doi: 10.1002/slct.202300130.", "ArticleIdList": ["10.1002/slct.202300130"]}, {"Citation": "Schad F., Steinmann D., Oei S.L., Thronicke A., Grah C. Evaluation of quality of life in lung cancer patients receiving radiation and Viscum album L.: A real-world data study. Radiat. Oncol. 2023;18:47. doi: 10.1186/s13014-023-02234-3.", "ArticleIdList": ["10.1186/s13014-023-02234-3", "PMC9990362", "36879290"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "14"}, {"Year": "2023", "Month": "3", "Day": "14"}, {"Year": "2023", "Month": "3", "Day": "16"}, {"Year": "2023", "Month": "4", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "4", "Day": "13", "Hour": "1", "Minute": "28"}, {"Year": "2023", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["37050086", "PMC10096603", "10.3390/plants12071460", "plants12071460"]}}], "PubmedBookArticle": []}